These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 21167321)
1. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321 [TBL] [Abstract][Full Text] [Related]
2. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Zhu Q; Liu M; Dai L; Ying X; Ye H; Zhou Y; Han S; Zhang JY Autoimmun Rev; 2013 Oct; 12(12):1123-8. PubMed ID: 23806562 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related]
4. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952 [TBL] [Abstract][Full Text] [Related]
5. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Shi FD; Zhang JY; Liu D; Rearden A; Elliot M; Nachtsheim D; Daniels T; Casiano CA; Heeb MJ; Chan EK; Tan EM Prostate; 2005 May; 63(3):252-8. PubMed ID: 15538718 [TBL] [Abstract][Full Text] [Related]
6. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
7. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to tumor-associated antigens: reporters from the immune system. Tan EM; Zhang J Immunol Rev; 2008 Apr; 222():328-40. PubMed ID: 18364012 [TBL] [Abstract][Full Text] [Related]
9. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer. Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875 [TBL] [Abstract][Full Text] [Related]
10. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer. Wang P; Qin J; Ye H; Li L; Wang X; Zhang J J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer. Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigen arrays for the serological diagnosis of cancer. Casiano CA; Mediavilla-Varela M; Tan EM Mol Cell Proteomics; 2006 Oct; 5(10):1745-59. PubMed ID: 16733262 [TBL] [Abstract][Full Text] [Related]
14. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer. Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955 [TBL] [Abstract][Full Text] [Related]
15. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596 [TBL] [Abstract][Full Text] [Related]
16. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma. Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146 [TBL] [Abstract][Full Text] [Related]
17. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a panel of tumor-associated antigens in breast cancer. Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604 [TBL] [Abstract][Full Text] [Related]
19. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]